Broad immune cell populations via secreted cytokines and extracellular vesicles (null)

Broad immune cell populations via secreted cytokines and extracellular vesicles Overview

The term "Broad immune cell populations via secreted cytokines and extracellular vesicles" refers to a complex physiological communication network rather than a single molecular target. This network facilitates the coordinated regulation of various immune cells, such as T cells, B cells, and myeloid cells, through two primary mediators: secreted cytokines and extracellular vesicles (EVs). Cytokines are small signaling proteins that bind to specific cell-surface receptors to induce immediate functional changes (NIH/NCBI, 2023), while EVs, including exosomes and microvesicles, serve as sophisticated transport vehicles for proteins, lipids, and nucleic acids, enabling long-range and multi-component signaling (Nature Reviews Molecular Cell Biology, 2018). In therapeutic development, this system is frequently leveraged by cell-based therapies, such as mesenchymal stem cells (MSCs), which utilize their "secretome" to modulate inflammatory environments and promote tissue regeneration (Journal of Extracellular Vesicles, 2019). Because this entry encompasses a vast array of distinct molecular entities and cell types, it is classified as a biological mechanism or systemic effect rather than a discrete, druggable therapeutic target.

Mechanism of Action

Modulation of diverse immune cell phenotypes through the paracrine and systemic delivery of signaling proteins (cytokines) and membrane-bound particles (extracellular vesicles) containing bioactive cargo.

Biological Functions

Safety Considerations

Associated Biomarkers